Johnson & Johnson - 54 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of December 20, 2024 is 144.47.
  • The all-time high Johnson & Johnson stock closing price was 171.65 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 168.85, which is 16.9% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 142.75, which is 1.2% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 155.80.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 153.2238 155.0389 166.0475 141.0615 144.4700 -4.90%
2023 152.9524 167.6575 169.5957 140.0005 151.9085 -8.60%
2022 160.1997 157.2792 171.6529 145.9340 166.2085 5.97%
2021 149.7798 139.9493 162.4952 137.7361 156.8483 11.45%
2020 128.5866 127.0464 140.7362 97.3616 140.7362 10.85%
2019 116.3005 108.9534 127.4554 107.2221 126.9593 15.35%
2018 111.8967 115.6138 126.0874 100.5173 110.0621 -5.14%
2017 106.3957 93.7707 118.6530 90.4680 116.0207 24.40%
2016 90.7261 79.1061 100.1423 75.3823 93.2608 15.32%
2015 77.3558 79.9056 82.8614 70.9111 80.8696 1.16%
2014 76.0540 67.7163 82.9636 64.4357 79.9439 17.34%
2013 62.8853 51.1474 71.1382 51.0751 68.1328 34.61%
2012 47.4565 45.8779 51.9052 43.8227 50.6131 10.83%
2011 43.4416 42.2100 46.4506 39.0936 45.6690 9.89%
2010 40.9990 41.9768 43.1820 37.6308 41.5582 -0.58%
2009 36.9094 38.0805 42.1585 29.5051 41.8016 11.28%
2008 40.1564 40.2474 44.9903 34.7402 37.5656 -7.77%
2007 38.5583 39.5370 41.7678 35.9350 40.7298 3.61%
2006 36.6062 35.8501 40.9117 33.0405 39.3107 12.44%
2005 37.2458 35.8781 39.7551 34.9252 34.9601 -3.36%
2004 31.5858 28.9013 36.3687 27.8146 36.1747 25.17%
2003 29.1623 30.4161 32.3810 27.1371 28.9013 -2.11%
2002 31.4630 31.8338 35.6277 22.8431 29.5255 -7.88%
2001 27.9911 27.2928 33.0649 22.3514 32.0508 13.97%
2000 23.7734 24.3789 28.1223 18.1798 28.1223 14.04%
1999 24.7341 21.6161 28.0573 20.1287 24.6593 12.46%
1998 19.4949 16.7881 23.2656 16.5146 21.9272 28.99%
1997 15.2896 12.6571 17.2732 12.6571 16.9997 34.31%
1996 12.2562 10.5598 13.6748 10.5598 12.6571 18.11%
1995 8.5575 6.7031 11.4685 6.6108 10.7164 59.14%
1994 5.6225 5.4317 6.8421 4.4389 6.7338 24.99%
1993 4.9798 5.7986 5.7986 4.2512 5.3873 -8.93%
1992 5.7296 6.4572 6.6948 5.0053 5.9157 -10.19%
1991 5.1161 3.9583 6.6442 3.7106 6.5867 62.34%
1990 3.5192 3.3160 4.1078 2.8796 4.0573 23.39%
1989 2.7434 2.2648 3.2883 2.2648 3.2883 42.63%
1988 2.1661 2.0642 2.3720 1.8592 2.3054 16.52%
1987 2.2612 1.7546 2.7496 1.6952 1.9786 15.80%
1986 1.6428 1.3221 1.9139 1.2169 1.7087 27.42%
1985 1.1202 0.8825 1.3953 0.8701 1.3410 49.85%
1984 0.8341 0.9784 1.0143 0.6875 0.8949 -8.53%
1983 1.0795 1.1572 1.1959 0.9394 0.9784 -15.66%
1982 0.9442 0.8357 1.1923 0.7461 1.1600 36.94%
1981 0.7695 0.7406 0.8668 0.6462 0.8471 14.53%
1980 0.5807 0.5535 0.7414 0.4829 0.7396 29.41%
1979 0.5128 0.5208 0.5769 0.4636 0.5715 10.48%
1978 0.5328 0.5146 0.6190 0.4547 0.5173 -1.77%
1977 0.4780 0.5252 0.5266 0.4233 0.5266 0.44%
1976 0.5769 0.5985 0.6392 0.4840 0.5243 -12.04%
1975 0.5882 0.5461 0.6545 0.4852 0.5961 12.03%
1974 0.6456 0.7295 0.7784 0.4930 0.5321 -27.71%
1973 0.7743 0.8351 0.8481 0.6822 0.7361 -13.21%
1972 0.7652 0.6329 0.8580 0.6142 0.8481 32.97%
1971 0.5499 0.3687 0.6402 0.3687 0.6378 73.74%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $345.687B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $719.145B 74.49
Novo Nordisk (NVO) Denmark $464.190B 33.48
AbbVie (ABBV) United States $303.100B 15.95
Merck (MRK) United States $251.749B 16.73
AstraZeneca (AZN) United Kingdom $199.805B 17.00
Novartis AG (NVS) Switzerland $197.798B 13.15
Pfizer (PFE) United States $146.038B 9.99
Sanofi (SNY) $120.547B 10.92
Innoviva (INVA) United States $1.122B 9.34